In July 2017 the Jamaica Anti-Doping Commission (JADCO) reported an anti-doping rule violation against the Athlete Jason Livermore after his sample tested positive for the prohibited susbstances Clomiphene and Mesterolone. After notification a provisional suspenstion was ordered. The Athlete filed a statement with evidence in his defence and he was heard for the Jamaica Anti-Doing Disciplinary Panel.
The Athlete admitted the violation and denied that the violation was intentional. He explained that he had used medication as treatment for his condition prescribed by his doctor as mentioned on the Doping Control Form and he was unaware that he had to apply for a TUE.
The Panel concludes that the violation was not intentional but also finds that the Athlete acted negligently since he failed to research his medication for prohibited nor applied for a TUE.
Therefore the Jamaica Anti-Doping Disciplinary Panel decides on 26 October 2017 to impose a 2 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 8 February 2017.
